SAN DIEGO & REHOVOT, Israel--(BUSINESS WIRE)--Nucleix, a liquid biopsy company revolutionizing cancer treatment by detecting the disease earlier, today announced that their San Diego-based clinical ...

Comprehensive pharmacogenetic assay focused on psychiatry and neurology advances precision medicine for the brain. KEARNY, N.J., Nov. 21, 2024 /PRNewswire/ -- NeuroKaire, a pioneering biotechnology ...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Mirvie, a pioneer in predicting unexpected pregnancy complications, today announced its South San Francisco-based laboratory has been certified by the ...

ST. LOUIS, July 29, 2025 /PRNewswire/ -- Panome Bio, a leader in advanced proteomic, metabolomic and transcriptional profiling technologies, announced it has achieved Clinical Laboratory Improvement ...

SEATTLE, March 7, 2024 /PRNewswire/ -- Key Proteo, a pioneering proteomics diagnostics company specializing in the early identification of rare but treatable genetic disorders, announced it has ...

Crown Bioscience, a global contract research organization (CRO) headquartered in the United States and part of JSR Life Sciences and Japan-based JSR Corporation, announced today that its San Diego ...

SAN DIEGO, Dec. 12, 2024 /PRNewswire/ -- LuminoDx is pleased to announce that its San Diego laboratory has recently received Clinical Laboratory Improvement Amendments (CLIA) certification. CLIA ...

CNSide now meets key federal and state regulatory requirements, including those set by the Centers for Medicare and Medicaid Services (CMS) under the Clinical Lab Improvement Amendments (CLIA) “This ...